224 results on '"CAGGIARI, LAURA"'
Search Results
2. Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors
3. Supplementary Figure 1 from IGKV3 Proteins as Candidate “Off-the-Shelf” Vaccines for Kappa-Light Chain–Restricted B-Cell Non-Hodgkin Lymphomas
4. Supplementary Figure Legend and Tables 1 - 5 from IGKV3 Proteins as Candidate “Off-the-Shelf” Vaccines for Kappa-Light Chain–Restricted B-Cell Non-Hodgkin Lymphomas
5. Supplementary Figure 2 from IGKV3 Proteins as Candidate “Off-the-Shelf” Vaccines for Kappa-Light Chain–Restricted B-Cell Non-Hodgkin Lymphomas
6. Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma
7. Successful Vaccination Induces Multifunctional Memory T-Cell Precursors Associated With Early Control of Hepatitis C Virus
8. HER2–CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients’ Survival in HER2-Positive Metastatic Gastric Adenocarcinoma
9. A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy
10. Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
11. Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications
12. PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases
13. Overview of Epstein–Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options
14. Kinetics of Lymphokine Production in HIV+ Patients Treated with Highly Active Antiretroviral Therapy and Interleukin 2
15. KIR/HLA combination associated with the risk of complications in celiac disease
16. KIR Molecules: Recent Patents of Interest for the Diagnosis and Treatment of Several Autoimmune Diseases, Chronic Inflammation, and B-cell Malignancies
17. Family’s History Based on the CDH1 Germline Variant (c.360delG) and a Suspected Hereditary Gastric Cancer Form
18. Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopes
19. Impact of a new genetic variant on FVII: C activity
20. HCV-Related Immunocytoma and Type II Mixed Cryoglobulinemia-Associated Autoantigens
21. Protein Expression Profile of Celiac Disease Patient with Aberrant T Cell by Two-dimensional Difference Gel Electrophoresis
22. Role of the HLA Class II: HCV-Related Disorders
23. Recent Patents Relating To HCV Molecules Like Putative Targets For Therapeutic Intervention
24. Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal Lymphomas
25. Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer
26. Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma
27. High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance
28. PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases.
29. Additional file 2: Table S1. of Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer
30. Additional file 1: Figure S1. of Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer
31. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients
32. Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype
33. HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma
34. A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach
35. Interference of PG2 TATA BOX region with the serum PG2 level in gastric cancer
36. Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer
37. Erratum: Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases (PLoS ONE (2015) 10:5 (e0128849) doi:10.1371/journal.pone.0128849)
38. Common mutations in immunoglobulin VK3 light chain sequences from B-cells of HCV-related disorders
39. HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2
40. A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach.
41. Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.
42. Molecular Signature in HCV-Positive Lymphomas
43. Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases
44. Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases
45. PD-001 - Interference of PG2 TATA BOX region with the serum PG2 level in gastric cancer
46. Improving detection of celiac disease patients
47. Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy
48. Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection
49. Prevalence of Antibodies to Human Herpesvirus 8 in Children from Sardinia and Croatia
50. Human immunodeficiency virus–associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.